PLK1 and its role in the evolving landscape of KRAS-mutated colorectal cancer

被引：1
作者：
Harvey, Harry [1 ]
Chen, Eric Xueyu [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, 7-824,700 Univ Ave, Toronto, ON M5G 1Z5, Canada
来源：
JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2024年 / 15卷 / 04期
关键词：
Kirsten rat sarcoma virus (KRAS); colorectal cancer (CRC); targeted therapy; RAS; INHIBITOR; FOLFIRI; BEVACIZUMAB; GEMCITABINE; COMBINATION; ISIS-2503;
D O I：
10.21037/jgo-24-323
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1987 / 1992
页数：6
相关论文
共 50 条
  • [21] Aurora Borealis (Bora), Which Promotes Plk1 Activation by Aurora A, Has an Oncogenic Role in Ovarian Cancer
    Parrilla, Alfonso
    Barber, Marta
    Majem, Blanca
    Castellvi, Josep
    Morote, Juan
    Luis Sanchez, Jose
    Perez-Benavente, Asuncion
    Segura, Miguel F.
    Gil-Moreno, Antonio
    Santamaria, Anna
    CANCERS, 2020, 12 (04)
  • [22] Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer
    Fogel, Elisha J.
    Samouha, Avishai
    Goel, Sanjay
    Maitra, Radhashree
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6743 - 6754
  • [23] A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non-Small Cell Lung Cancer
    Vasan, Neil
    Boyer, Julie L.
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3921 - 3930
  • [24] Inhibition of PLK1 Destabilizes EGFR and Sensitizes EGFR-Mutated Lung Cancer Cells to Small Molecule Inhibitor Osimertinib
    Eggermont, Carolien
    Gutierrez, Gustavo J.
    De Greve, Jacques
    Giron, Philippe
    CANCERS, 2023, 15 (09)
  • [25] The effect of deuterated PLK1 inhibitor on its safety and efficacy in vivo
    Zhang, Tingyan
    Deng, Xiaobing
    Jin, Haoping
    Peng, Zhengshu
    Hsueh, Yi-Ching
    Zhang, Chunming
    Niu, Gang
    Yang, Jianfei
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [26] Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer
    Bonetti, Luca Reggiani
    Barresi, Valeria
    Bettelli, Stefania
    Caprera, Cecilia
    Manfredini, Samantha
    Maiorana, Antonio
    HUMAN PATHOLOGY, 2017, 62 : 91 - 98
  • [27] Regulation of intestinal myofibroblasts by KRas-mutated colorectal cancer cells through heparin-binding epidermal growth factor-like growth factor
    Kawasaki, Hideyoshi
    Saotome, Takuya
    Usui, Tatsuya
    Ohama, Takashi
    Sato, Koichi
    ONCOLOGY REPORTS, 2017, 37 (05) : 3128 - 3136
  • [28] PLK1 inhibition-based combination therapies for cancer management
    Su, Shengqin
    Chhabra, Gagan
    Singh, Chandra K.
    Ndiaye, Mary A.
    Ahmad, Nihal
    TRANSLATIONAL ONCOLOGY, 2022, 16
  • [29] Reverse Engineering of DNA and RNA Hybrid Origami Structures as Targeted Nanomedicine for KRAS-Mutated Lung Cancer Therapy
    Ding, Xiaotong
    Chen, Chunfa
    Liu, Qian
    Yang, Yao
    Wang, Guansong
    Qian, Hang
    ACS APPLIED POLYMER MATERIALS, 2023, 5 (08) : 5880 - 5887
  • [30] An Evolving Landscape: New Therapies for Metastatic Colorectal Cancer
    Mo, Christiana
    Chadha, Bhawneet
    Kuang, Chaoyuan
    CLINICAL COLORECTAL CANCER, 2024, 23 (04) : 337 - 345
12345